InsiderTrades.com logo

YMAB Insider Trading

Insider Ownership Percentage: 22.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $2,618,929.67

Y-mAbs Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Y-mAbs Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Y-mAbs Therapeutics Share Price & Price History

Current Price: $4.11
Price Change: ▼ Price Decrease of -0.013 (-0.32%)
As of 04/24/2025 04:26 PM ET

This chart shows the closing price history over time for YMAB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Y-mAbs Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/7/2025Michael J RossiCEOSell3,917$5.20$20,368.40137,083View SEC Filing Icon  
3/7/2025Thomas GadInsiderSell10,810$5.23$56,536.30202,721View SEC Filing Icon  
9/16/2024Thomas GadInsiderSell30,000$12.97$389,100.0067,681View SEC Filing Icon  
9/13/2024Thomas GadInsiderSell65,000$13.47$875,550.0097,681View SEC Filing Icon  
8/26/2024Joris WilmsCOOSell5,000$14.69$73,450.0030,600View SEC Filing Icon  
6/10/2024Gerard BerDirectorSell722$12.00$8,664.001,608View SEC Filing Icon  
6/10/2024Thomas GadInsiderSell35,000$12.03$421,050.00197,681View SEC Filing Icon  
5/31/2024Bo KruseCFOSell31,371$12.07$378,647.97210,877View SEC Filing Icon  
5/23/2024Thomas GadInsiderSell7,351$13.00$95,563.00232,681View SEC Filing Icon  
5/21/2024Thomas GadInsiderSell25,000$12.00$300,000.00240,032View SEC Filing Icon  
3/5/2024Vignesh RajahSVPSell1,711$16.53$28,282.8333,889View SEC Filing Icon  
12/15/2023Thomas GadInsiderSell50,000$6.61$330,500.00265,032View SEC Filing Icon  
12/13/2023Thomas GadInsiderSell50,000$6.58$329,000.00365,032View SEC Filing Icon  
12/11/2023Biotech Aps WgDirectorBuy102,863$7.01$721,069.634,552,778View SEC Filing Icon  
12/7/2023Biotech Aps WgDirectorBuy6,183$6.50$40,189.504,431,412View SEC Filing Icon  
11/29/2023Biotech Aps WgDirectorBuy51,837$5.97$309,466.894,425,229View SEC Filing Icon  
11/27/2023Johan Wedell-WedellsborgDirectorBuy62,516$5.49$343,212.844,342,721View SEC Filing Icon  
11/20/2023Thomas GadInsiderSell75,000$5.30$397,500.00490,032View SEC Filing Icon  
5/15/2023Johan Wedell-WedellsborgDirectorBuy101,740$9.65$981,791.004,280,205View SEC Filing Icon  
11/15/2022Vignesh RajahCMOBuy1,195$4.92$5,879.404,266View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Y-mAbs Therapeutics (NASDAQ:YMAB)

70.85% of Y-mAbs Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at YMAB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Y-mAbs Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/17/2025Exchange Traded Concepts LLC26,762$0.12M0.0%+107.9%0.059%Search for SEC Filing on Google Icon
4/14/2025Wesbanco Bank Inc.55,000$0.24M0.0%N/A0.122%Search for SEC Filing on Google Icon
4/8/2025Rhumbline Advisers53,909$0.24M0.0%+4.8%0.119%Search for SEC Filing on Google Icon
3/24/2025Wellington Management Group LLP133,263$1.04M0.0%-2.5%0.295%Search for SEC Filing on Google Icon
2/26/2025Infinitum Asset Management LLC155,529$1.22M0.6%N/A0.347%Search for SEC Filing on Google Icon
2/17/2025UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC52,356$0.41M0.0%+17.4%0.117%Search for SEC Filing on Google Icon
2/17/2025Soleus Capital Management L.P.349,982$2.74M0.2%-12.5%0.781%Search for SEC Filing on Google Icon
2/17/2025Squarepoint Ops LLC102,968$0.81M0.0%-33.5%0.230%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Advisers LP73,900$0.58M0.0%-13.1%0.165%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Investments LP88,337$0.69M0.0%+31.6%0.197%Search for SEC Filing on Google Icon
2/17/2025Rafferty Asset Management LLC41,255$0.32M0.0%+17.6%0.092%Search for SEC Filing on Google Icon
2/17/2025ProShare Advisors LLC12,645$99K0.0%N/A0.028%Search for SEC Filing on Google Icon
2/17/2025Paradigm Biocapital Advisors LP4,236,346$33.17M1.2%+3.7%9.458%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC35,447$0.28M0.0%-50.5%0.079%Search for SEC Filing on Google Icon
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.22,818$0.18M0.0%+12.6%0.051%Search for SEC Filing on Google Icon
2/17/2025Deutsche Bank AG32,253$0.25M0.0%+52.2%0.072%Search for SEC Filing on Google Icon
2/17/2025D. E. Shaw & Co. Inc.615,131$4.82M0.0%-21.9%1.373%Search for SEC Filing on Google Icon
2/17/2025Cubist Systematic Strategies LLC48,011$0.38M0.0%N/A0.107%Search for SEC Filing on Google Icon
2/17/2025Bridgeway Capital Management LLC49,900$0.39M0.0%-34.3%0.111%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE127,159$1M0.0%+59.5%0.284%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets4,874$38K0.0%-81.6%0.011%Search for SEC Filing on Google Icon
2/17/2025Acorn Capital Advisors LLC2,861,825$22.41M12.3%N/A6.389%Search for SEC Filing on Google Icon
2/14/2025Caligan Partners LP1,767,982$13.84M3.7%+47.9%3.947%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC33,203$0.26M0.0%-14.7%0.074%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp359,223$2.81M0.0%+6.5%0.802%Search for SEC Filing on Google Icon
2/14/2025Boothbay Fund Management LLC693,693$5.43M0.1%+24.4%1.549%Search for SEC Filing on Google Icon
2/14/2025Virtus ETF Advisers LLC35,789$0.28M0.1%+30.9%0.080%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD14,067$0.11M0.0%-37.6%0.031%Search for SEC Filing on Google Icon
2/14/2025Dimensional Fund Advisors LP463,235$3.63M0.0%-3.0%1.034%Search for SEC Filing on Google Icon
2/13/2025Marshall Wace LLP49,225$0.39M0.0%+217.4%0.110%Search for SEC Filing on Google Icon
2/13/2025Jump Financial LLC33,380$0.26M0.0%N/A0.075%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd20,768$0.16M0.0%+83.8%0.046%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC75,862$0.59M0.0%+9.6%0.169%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC131,600$1.03M0.0%+371.7%0.294%Search for SEC Filing on Google Icon
2/13/2025Legal & General Group Plc34,942$0.27M0.0%-7.3%0.078%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN17,458$0.14M0.0%+54.1%0.039%Search for SEC Filing on Google Icon
2/12/2025ExodusPoint Capital Management LP32,256$0.25M0.0%N/A0.072%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC822,309$6.44M0.0%+1.1%1.836%Search for SEC Filing on Google Icon
2/12/2025Wellington Management Group LLP133,263$1.04M0.0%-2.5%0.298%Search for SEC Filing on Google Icon
2/12/2025Pictet Asset Management Holding SA756,297$5.92M0.0%+9.9%1.689%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.97,660$0.77M0.0%+221.9%0.218%Search for SEC Filing on Google Icon
2/11/2025Prudential Financial Inc.18,625$0.15M0.0%-39.2%0.042%Search for SEC Filing on Google Icon
2/11/2025Vanguard Group Inc.2,000,022$15.66M0.0%-1.7%4.465%Search for SEC Filing on Google Icon
2/11/2025KLP Kapitalforvaltning AS5,900$46K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/7/2025AlphaQuest LLC27,135$0.21M0.0%+6,911.6%0.061%Search for SEC Filing on Google Icon
2/6/2025Charles Schwab Investment Management Inc.284,540$2.23M0.0%+1.8%0.635%Search for SEC Filing on Google Icon
1/31/2025Principal Financial Group Inc.22,197$0.17M0.0%+9.4%0.050%Search for SEC Filing on Google Icon
1/17/2025SG Americas Securities LLC17,729$0.14M0.0%+30.7%0.040%Search for SEC Filing on Google Icon
12/26/2024JPMorgan Chase & Co.30,335$0.40M0.0%+10.4%0.068%Search for SEC Filing on Google Icon
12/19/2024Principal Financial Group Inc.20,294$0.27M0.0%N/A0.045%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC69,222$0.91M0.0%+433.4%0.155%Search for SEC Filing on Google Icon
11/18/2024Empire Financial Management Company LLC16,000$0.21M0.1%N/A0.036%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC813,489$10.70M0.0%+6.2%1.816%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC69,222$0.91M0.0%+433.4%0.155%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd11,300$0.15M0.0%-54.1%0.025%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP136,714$1.80M0.0%-14.8%0.305%Search for SEC Filing on Google Icon
11/15/2024State Street Corp1,209,781$15.91M0.0%+50.4%2.701%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.95,383$1.25M0.0%-73.4%0.213%Search for SEC Filing on Google Icon
11/14/2024Caligan Partners LP1,195,253$15.72M5.0%+105.3%2.669%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC44,591$0.59M0.0%-23.5%0.100%Search for SEC Filing on Google Icon
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank3,324$44K0.0%N/A0.007%Search for SEC Filing on Google Icon
11/13/2024FMR LLC36,416$0.48M0.0%+23.1%0.081%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.279,577$3.68M0.0%+9.4%0.627%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC10,149$0.13M0.0%N/A0.023%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.94,225$1.24M0.0%-46.5%0.211%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.20,294$0.27M0.0%N/A0.046%Search for SEC Filing on Google Icon
10/28/2024Rice Hall James & Associates LLC108,684$1.43M0.1%+21.1%0.244%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.8,572$0.11M0.0%+66.3%0.020%Search for SEC Filing on Google Icon
10/10/2024Exchange Traded Concepts LLC12,872$0.17M0.0%-11.2%0.029%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC13,566$0.18M0.0%N/A0.031%Search for SEC Filing on Google Icon
9/16/2024Cubist Systematic Strategies LLC6,597$80K0.0%-91.5%0.015%Search for SEC Filing on Google Icon
8/19/2024Point72 Asset Management L.P.358,945$4.34M0.0%-76.5%0.818%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC349,784$4.23M0.0%+23.8%0.797%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC21,926$0.27M0.0%-42.1%0.050%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC126,389$1.53M0.0%+143.4%0.288%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC6,597$80K0.0%-91.5%0.015%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd24,621$0.30M0.0%N/A0.056%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC64,637$0.78M0.0%-43.9%0.147%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP484,431$5.85M0.0%+15.7%1.104%Search for SEC Filing on Google Icon
8/9/2024Massachusetts Financial Services Co. MA82,202$0.99M0.0%+3.5%0.187%Search for SEC Filing on Google Icon
8/8/2024Rice Hall James & Associates LLC89,735$1.08M0.1%+4.2%0.204%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC323,175$3.90M0.0%-46.3%0.736%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp120,954$1.46M0.0%+8.0%0.276%Search for SEC Filing on Google Icon
5/28/2024Boston Partners34,165$0.56M0.0%N/A0.078%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System3,700$60K0.0%-38.9%0.008%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.154,016$2.50M0.0%-39.1%0.351%Search for SEC Filing on Google Icon
5/16/2024Caxton Associates LP18,807$0.31M0.0%N/A0.043%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD21,158$0.35M0.0%+8.5%0.048%Search for SEC Filing on Google Icon
5/13/2024Ameritas Investment Partners Inc.3,701$60K0.0%+39.9%0.008%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC602,314$9.79M0.0%-24.9%1.373%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,069,517$33.65M0.0%-7.8%4.717%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC11,963$0.20M0.0%-44.5%0.027%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.13,729$0.22M0.0%-7.4%0.031%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.8,390$0.14M0.0%+66.1%0.019%Search for SEC Filing on Google Icon
4/5/2024Los Angeles Capital Management LLC127,551$2.07M0.0%-64.2%0.291%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC6,686$46K0.0%+345.4%0.015%Search for SEC Filing on Google Icon
2/13/2024Campbell & CO Investment Adviser LLC82,391$0.56M0.1%N/A0.189%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP28,616$0.20M0.0%-62.6%0.066%Search for SEC Filing on Google Icon
2/8/2024Massachusetts Financial Services Co. MA79,617$0.54M0.0%-3.1%0.183%Search for SEC Filing on Google Icon
2/6/2024Sapient Capital LLC43,700$0.30M0.0%N/A0.100%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Y-mAbs Therapeutics logo
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer in the United States and internationally. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment of pediatric patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow. The company is also developing DANYELZA for the treatment of patients with second-line relapsed osteosarcoma and is in Phase II clinical study; GD2-SADA, which is in Phase I clinical trial for the treatment of GD2 positive solid tumor; and Omburtamab, a murine monoclonal antibody for the treatment of central nervous system/leptomeningeal metastases from neuroblastoma, as well as SADA PRIT technology platform. In addition, it is engages in the developing of CD38-SADA and GD2-GD3 Vaccine. The company has a license agreement with Memorial Sloan Kettering Cancer Center and Massachusetts Institute of Technology to develop and commercialize licensed products. Y-mAbs Therapeutics, Inc. was incorporated in 2015 and is headquartered in New York, New York.
Read More on Y-mAbs Therapeutics

Today's Range

Now: $4.11
Low: $3.91
High: $4.07

50 Day Range

MA: $4.95
Low: $4.09
High: $6.42

52 Week Range

Now: $4.11
Low: $3.84
High: $17.78

Volume

120,472 shs

Average Volume

327,717 shs

Market Capitalization

$185.71 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.71

Who are the company insiders with the largest holdings of Y-mAbs Therapeutics?

Y-mAbs Therapeutics' top insider shareholders include:
  1. Biotech Aps Wg (Director)
  2. Johan Wedell-Wedellsborg (Director)
  3. Thomas Gad (Insider)
  4. Bo Kruse (CFO)
  5. Michael J Rossi (CEO)
  6. Vignesh Rajah (SVP)
  7. Joris Wilms (COO)
  8. Gerard Ber (Director)
Learn More about top insider investors at Y-mAbs Therapeutics.

Who are the major institutional investors of Y-mAbs Therapeutics?

Y-mAbs Therapeutics' top institutional shareholders include:
  1. Wesbanco Bank Inc. — 0.12%
  2. Rhumbline Advisers — 0.12%
  3. Exchange Traded Concepts LLC — 0.06%
Learn More about top institutional investors of Y-mAbs Therapeutics stock.

Which major investors are buying Y-mAbs Therapeutics stock?

Within the last quarter, YMAB stock was bought by institutional investors including:
  1. Wesbanco Bank Inc.
  2. Exchange Traded Concepts LLC
  3. Rhumbline Advisers
Within the previous year, these company insiders have bought Y-mAbs Therapeutics stock:
  1. Biotech Aps Wg (Director)
  2. Johan Wedell-Wedellsborg (Director)
Learn More investors buying Y-mAbs Therapeutics stock.